LeMaitre director acquires dividend-equivalent rights

Q: What insider transaction did LMAT director Lawrence J. Jasinski report?

He reported the acquisition of Dividend Equivalent Rights on September 3, 2026. These rights accrued on previously granted restricted stock unit and performance share unit awards and are the economic equivalent of one share of LeMaitre common stock for each right, vesting with the underlying awards.

Q: How many Dividend Equivalent Rights did Lawrence J. Jasinski acquire in this LMAT Form 4?

The filing lists several separate acquisitions, including 0.5429, 0.6503, 0.8852, 1.0022, and 1.6637 Dividend Equivalent Rights, each tied to a different prior equity award. Each right is the economic equivalent of one share of LMAT common stock.

Q: What are Dividend Equivalent Rights reported in LMAT’s Form 4?

The filing states that each Dividend Equivalent Right is the economic equivalent of one share of LeMaitre common stock. They accrued on existing restricted stock unit and performance share unit awards and will vest proportionately with those underlying awards instead of as standalone grants.

Q: Did LeMaitre Vascular or Lawrence J. Jasinski report using a Rule 10b5-1 plan?

No. The Form 4 indicates that the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating that these transactions were made pursuant to a Rule 10b5-1 or other pre-arranged trading plan.

LMAT director Lawrence J. Jasinski received additional dividend equivalent rights tied to prior equity awards, economically mirroring common stock.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

LeMaitre Vascular Inc (LMAT) director Lawrence J. Jasinski reported the acquisition of several small blocks of Dividend Equivalent Rights on September 3, 2026. These rights accrued on previously granted restricted stock unit and performance share unit awards and are the economic equivalent of LeMaitre common shares, vesting proportionately with the underlying awards. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Grant/Award: 4.7443 shares

Grant/Award 5 txns

Insider Jasinski Lawrence J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Dividend Equivalent Rights ^F1	0.5429	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights ^F2	0.6503	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights ^F3	0.8852	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights ^F4	1.0022	$0.00	$0.00
Grant/Award	Dividend Equivalent Rights ^F5	1.6637	$0.00	$0.00

Holdings After Transaction: Dividend Equivalent Rights — 26.0982 contracts (Direct)

Footnotes (5)

F1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Key Figures

Dividend Equivalent Rights acquired (RSU-related, 2023 grant): 0.5429 rights Dividend Equivalent Rights acquired (PSU-related, 2023 grant): 0.6503 rights Dividend Equivalent Rights acquired (RSU-related, 2024 grant): 0.8852 rights +2 more

5 metrics

Dividend Equivalent Rights acquired (RSU-related, 2023 grant) 0.5429 rights Accrued on a restricted stock unit award granted on December 8, 2023; reported September 3, 2026

Dividend Equivalent Rights acquired (PSU-related, 2023 grant) 0.6503 rights Accrued on a performance share unit award granted on December 8, 2023; reported September 3, 2026

Dividend Equivalent Rights acquired (RSU-related, 2024 grant) 0.8852 rights Accrued on a restricted stock unit award granted on December 6, 2024; reported September 3, 2026

Dividend Equivalent Rights acquired (PSU-related, 2024 grant) 1.0022 rights Accrued on a performance share unit award granted on December 6, 2024; reported September 3, 2026

Dividend Equivalent Rights acquired (RSU-related, 2025 grant) 1.6637 rights Accrued on a restricted stock unit award granted on December 10, 2025; reported September 3, 2026

Key Terms

Dividend Equivalent Rights, restricted stock unit, performance share unit, economic equivalent, +1 more

5 terms

Dividend Equivalent Rights financial

"These dividend equivalent rights accrued on a restricted stock unit award"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

restricted stock unit financial

"accrued on a restricted stock unit award granted on 12/8/2023"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

economic equivalent financial

"Each dividend equivalent right is the economic equivalent of one share"

common stock financial

"economic equivalent of one share of the Issuer's common stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did LMAT director Lawrence J. Jasinski report?

He reported the acquisition of Dividend Equivalent Rights on September 3, 2026. These rights accrued on previously granted restricted stock unit and performance share unit awards and are the economic equivalent of one share of LeMaitre common stock for each right, vesting with the underlying awards.

How many Dividend Equivalent Rights did Lawrence J. Jasinski acquire in this LMAT Form 4?

The filing lists several separate acquisitions, including 0.5429, 0.6503, 0.8852, 1.0022, and 1.6637 Dividend Equivalent Rights, each tied to a different prior equity award. Each right is the economic equivalent of one share of LMAT common stock.

What are Dividend Equivalent Rights reported in LMAT’s Form 4?

The filing states that each Dividend Equivalent Right is the economic equivalent of one share of LeMaitre common stock. They accrued on existing restricted stock unit and performance share unit awards and will vest proportionately with those underlying awards instead of as standalone grants.

Are the LMAT Dividend Equivalent Rights subject to vesting conditions?

Yes. For each transaction, the filing notes that the Dividend Equivalent Rights vest proportionately with the related restricted stock unit or performance share unit award granted on December 8, 2023, December 6, 2024, or December 10, 2025, as applicable.

Did LeMaitre Vascular or Lawrence J. Jasinski report using a Rule 10b5-1 plan?

No. The Form 4 indicates that the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating that these transactions were made pursuant to a Rule 10b5-1 or other pre-arranged trading plan.

Do the Dividend Equivalent Rights for LMAT have a purchase price?

No. Each reported acquisition of Dividend Equivalent Rights shows a transaction price per right of $0.0000, indicating they were awarded in connection with prior equity grants rather than purchased in the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/08/2026 - 04:49 PM EDT Accepted by SEC EDGAR 09/08/2026 - 04:48 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jasinski Lawrence J

(Last)

(First)

(Middle)

C/O LEMAITRE VASCULAR, INC.

63 SECOND AVENUE

(Street)

BURLINGTON

MASSACHUSETTS

01803

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Dividend Equivalent Rights	⁽¹⁾	09/03/2026		A		0.5429		⁽¹⁾	⁽¹⁾	Common Stock	0.5429	$0	5.6103	D
Dividend Equivalent Rights	⁽²⁾	09/03/2026		A		0.6503		⁽²⁾	⁽²⁾	Common Stock	0.6503	$0	5.5195	D
Dividend Equivalent Rights	⁽³⁾	09/03/2026		A		0.8852		⁽³⁾	⁽³⁾	Common Stock	0.8852	$0	5.1836	D
Dividend Equivalent Rights	⁽⁴⁾	09/03/2026		A		1.0022		⁽⁴⁾	⁽⁴⁾	Common Stock	1.0022	$0	5.486	D
Dividend Equivalent Rights	⁽⁵⁾	09/03/2026		A		1.6637		⁽⁵⁾	⁽⁵⁾	Common Stock	1.6637	$0	4.2988	D

Explanation of Responses:

1. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

2. These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

3. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

4. These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

5. These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

	/s/ Douglas G. Bush, Attorney-in-fact	09/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR